A Joomla! Template for the Rest of Us
|Cardiovascular Disease - Therapeutic Lifestyle Changes (TLC)|
Page 3 of 11
Therapeutic Lifestyle Changes (TLC)
Therapeutic Lifestyle Changes (TLC) are recommended as a first line treatment for a variety of common health
problems by many national health organizations, including:
Lifestyle-related, chronic health problems:
FirstLine Therapy® (FLT) is a therapeutic lifestyle changes (TLC) program that is clinically effective, yet easy to implement. FLT provides time-saving tools that make it easy for you to integrate recommendations for diet and exercise with medical foods and other lifestyle changes, in a format that patients can understand and follow.
Most importantly, patients get results with the FLT program. Many are able to achieve their risk-reduction goals without medication in as little as 12 weeks on FLT.
Moderate Risk Reduction
Wellness Essentials Cardiovascular Support is a combination of essential vitamins and minerals, omega-3 fatty acids, antioxidants, and phytonutrients to promote healthy cardiovascular function and overall well-being.
CardioauxinTM is a very efficacious lipid-lowering, heart risk reduction formula. This formula contains
a unique combination of synergistic nutrients that proved to significantly lower low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG), while raising protective high-density lipoprotein cholesterol (HDL-C).
Therapeutic Lifestyle Change
Severe Risk Reduction
FLT uses a low-glycemic-index dietary regimen and exercise program while incorporating medical foods and nutritional supplements. New research has shown that low glycemic diets are more
effective than low fat diets in treating obesity, insulin resistance, dyslipidemia, cardiovascular disease and type-2 diabetes.
UltraMeal Plus 360 is a medical food formulated to provide specialized, multi-mechanistic
nutritional support for patients with metabolic syndrome and cardiovascular disease by supplying a combination of acacia extract, reduced iso-alpha acids (RIAA), plant sterols, and heart-healthy soy protein and isoflavones.
Concentrated and Stabilized Purity-Certified, Omega-3 Fatty Acids
Cardioauxin is a very efficacious lipid-lowering, heart risk reduction formula.
Taken orally, red yeast extract is used to reduce and maintain desirable cholesterol and lipoprotein
levels in hyperlipidemic individuals.
If your patients are on cholesterol lowering drugs (e.g. statins), consider adding:
CoQ-10 ST-100TM - 1-2 softgels daily
CoQ-10 ST features 30 mg of a stabilized, all natural encapsulation of coenzyme Q10 (CoQ10) manufactured to achieve exquisite quality, purity, and bioavailability
The depletion of the essential nutrient CoQ10 by the increasingly popular cholesterol lowering drugs, HMG CoA reductase inhibitors (statins), has grown from a level of concern to one of alarm. With ever higher statin potencies and dosages, and with a steadily shrinking target LDL cholesterol, the prevalence and severity of CoQ10 deficiency
is increasing noticeably. An estimated 36 million Americans are now candidates for statin drug therapy. Statin- induced CoQ10 depletion is well documented in animal and human studies with detrimental cardiac consequences
in both animal models and human trials. This drug-induced nutrient deficiency is dose related and more notable
in settings of pre-existing CoQ10 deficiency such as in the elderly and in heart failure.1
Published data already indicated that statins can cause myopathies and rhabdomyolysis with renal failure. Moreover, on May 1, 2000, the FDA issued a warning about liver failure as an adverse reaction of statin use, based on reports that more than half of 62 patients with liver failure died. An estimate claims that the drugs can cause liver and muscle injury in up to 1% of users. For the US this will equal up to 130,000 patients with liver and muscle toxicity symptoms. Moreover, statins use is also implicated the increased incidence of cataracts, neoplasia, peripheral neuropathies, and some psychiatric disturbances.2
Statin-induced CoQ10 deficiency is completely preventable with supplemental CoQ10 with no adverse impact
on the cholesterol lowering or anti-inflammatory properties of the statin drugs.1
|Last Updated on Thursday, 26 May 2011 20:51|